On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...

Researchers at the Boston University School of Public Health analyzed data from more than 4,300 people in the Framingham ...

Since the landmark approvals of lecanemab and donanemab, anti-amyloid immunotherapy has marked a paradigm shift in ...

Emerging evidence suggests there may be a critical window for estrogen therapy to protect against cognitive decline later in ...

Researchers say monitoring how older people drive could help catch brain changes early before car crashes happen.

Building understanding. Bridging generations. Changing how we see dementia. An intergenerational Project by Alzheimer’s ...

Hospitalization for infections significantly increases long-term dementia risk, highlighting the need for prevention and ...

Scientists have found that a mutation tied to Alzheimer’s disrupts the production and quality of exosomes—tiny cell-made ...

A new analysis shows that 54% of the US population is affected by a medical condition that affects nervous system health, ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

With dementia now estimated to impact 42 percent of people who make it past age 55, everyone should be taking steps to help ...

But in people with dementia —which is an umbrella term for mental decline and can be related to a number of diseases such as ...